Search

everythinglearnresearchcommunity

for

Search:↓

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

ΔNp63α helps control a protein that stops cancer cells from spreading.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

CIP/KIP proteins help stop cell division and support hair growth.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Testosterone affects brain functions and contributes to sex differences, influencing conditions like autism.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Hormonal therapies help treat female hair loss, but results are slow and vary.

No link found between new male baldness genes and female hair loss.

Honokiol helps protect skin from damage and aging caused by cigarette smoke.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Aromatase inhibitors cause male pattern hair loss in women.

No link found between specific genes and female pattern hair loss.